CKD-MBD - B
Tilman B. Drüeke(Inserm), J.-M. Hurot(NephroCare Tassin-Charcot), Farah Ali(United Nations Children's Fund Niger), J. M. Górriz(Universidad de Granada), Charles Chazot(Clinique Charcot), Jorge B. Cannata‐Andía(Universidad de Oviedo), Patrick Deléaval(NephroCare Tassin-Charcot), Ercan Ok(University of Michigan), Christie Lorriaux(Association pour l'Utilisation du Rein Artificiel), Paul Brenchley(Manchester Academic Health Science Centre), Willem Jan W. Bos(St. Antonius Ziekenhuis), António Ferreira, Dimitrios Memmos, Adrian Covic(Grigore T. Popa University of Medicine and Pharmacy), Mustafa Yaprak(Mustafa Kemal University), Kody J. H. Law(Manchester University NHS Foundation Trust), A. Hutchison(University of Sussex), J. Nagy, F. Locatelli(Alessandro Manzoni Hospital), G. London, Ali Rıza Şişman(Ege University), John T. Lear(Salford Royal Hospital), Guillaume Jean(NephroCare Tassin-Charcot), Brice Mayor(Association pour l'Utilisation du Rein Artificiel), M. Ozkahya(Ege University), Mehmet Nuri Turan(Ege University), Julián Fernández-Martín(Universidad de Oviedo), Ramya Bhargava(Manchester University NHS Foundation Trust), J. Floege(Universitätsklinikum Aachen), Fatih Kırçelli, Nicholas Bryan(University of Liverpool), Mümtaz Yılmaz(Ege University)
Cited by 1
Related Papers
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
|New England Journal of Medicine|2006|2.1k
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
|New England Journal of Medicine|2004|1.1k
Non-melanoma skin cancer
|The Lancet|2010|874
Survival as an index of adequacy of dialysis
|Kidney International|1992|769